Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learning

Volume: 2, Issue: 10, Pages: 761 - 772
Published: Sep 17, 2018
Abstract
The risk stratification of prostate cancer and breast cancer tumours from patients relies on histopathology, selective genomic testing, or on other methods employing fixed formalin tissue samples. However, static biomarker measurements from bulk fixed-tissue samples provide limited accuracy and actionability. Here, we report the development of a live-primary-cell phenotypic-biomarker assay with single-cell resolution, and its validation with...
Paper Details
Title
Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learning
Published Date
Sep 17, 2018
Volume
2
Issue
10
Pages
761 - 772
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.